US · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at 0.60 against a street estimate of 0.56 — a beat of 7.1%.
Analysts rate Perrigo Company PLC a hold (1 buy, 4 hold, 0 sell out of 5) with an average price target of $18.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 16.36% |
| Neuberger Berman Group LLC | 7.70% |
| Vanguard Portfolio Management, LLC | 6.52% |
| T. Rowe Price Associates, Inc. | 6.27% |
| State Street Corp | 6.15% |
| Fuller & Thaler Asset Management Inc | 5.40% |
| Vanguard Capital Management, LLC | 4.50% |
| Amvescap Plc. | 4.23% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter net sales were $988.6 million, down from $1,043.3 million in the prior-year quarter. • Nine-month net sales were $2 | 2026-11-04 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 reported net sales were $989 million, down 5.2% year over year; Core net sales were $908 million, down 1.7%. • | 2026-11-04 |
| Reg FD disclosure · Q4 2026 HEADLINE NUMBERS • On October 29, 2026, Perrigo Company plc announced it had entered into a definitive agreement to sell its Infant Formula business. | 2026-10-29 |
| Quarterly report · Q2 2026 PERRIGO COMPANY PLC - FORM 10-Q SUMMARY Quarter Ended June 27, 2026 --- HEADLINE NUMBERS • Net sales Q2 2026: $1,022.8 million (down 3.2% vs Q2 202 | 2026-08-05 |
| Results announced · Q3 2026 PERRIGO COMPANY PLC - Q2 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Core Net Sales: $907 million, down 3.1% year-over-year (3.5% organic decline) • A | 2026-08-05 |
| Board / officer change · Q2 2026 PERRIGO COMPANY PLC - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial performance data disclosed in this filing • Filing date: June 29, 2026 • Comp | 2026-07-06 |
| Board / officer change · Q2 2026 PERRIGO COMPANY PLC - FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Board Expansion & New Appointments: Board size increased from 8 to 10 directo | 2026-06-30 |
| Board / officer change · Q2 2026 PERRIGO COMPANY PLC - 8-K SUMMARY HEADLINE NUMBERS • CEO Departure: Patrick Lockwood-Taylor resigned effective immediately on June 7, 2026, as Presi | 2026-06-08 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.29 / share ex-date Nov 27, 2026 · pay Dec 15, 2026 | 2026-11-27 |
| Dividend | $0.29 / share ex-date Aug 28, 2026 · pay Sep 15, 2026 | 2026-08-28 |
| Dividend | $0.29 / share ex-date May 29, 2026 · pay Jun 5, 2026 | 2026-05-29 |
| Dividend | $0.29 / share ex-date Mar 2, 2026 · pay Mar 24, 2026 | 2026-03-02 |
| Dividend | $0.29 / share ex-date Nov 28, 2025 · pay Dec 16, 2025 | 2025-11-28 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Perrigo Company PLC — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.